Barra F, Ferrero S. Epigenetic Drugs in the Treatment of Endometriosis. Reprod Sci 2018:1933719118765987. https://journals.sagepub.com/doi/abs/10.1177/1933719118765987?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=rsxb
Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder.
Rosa GM, Baccino D, Valbusa A, Scala C, Barra F, Brunelli C, Ferrero S. Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder. Expert Opin Drug Saf 2018;17:487-497. https://www.tandfonline.com/doi/abs/10.1080/14740338.2018.1453496?journalCode=ieds20
Regarding “Does Ulipristal Acetate Affect Surgical Experience at Laparoscopic Myomectomy?”
Ferrero S, Scala C, Barra F. Regarding “Does Ulipristal Acetate Affect Surgical Experience at Laparoscopic Myomectomy?” J Minim Invasive Gynecol 2018;25:541. https://www.jmig.org/article/S1553-4650(17)31284-0/fulltext
To the Editor. Menopause
Leone Roberti Maggiore U, Ferrero S. To the Editor. Menopause 2018;25:357. https://journals.lww.com/menopausejournal/Citation/2018/03000/To_the_Editor.18.aspx
The delicate balance between the good and the bad IL-1 proinflammatory effects in endometriosis.
Sikora J, Ferrero S, Mielczarek-Palacz A, Kondera-Anasz Z. The delicate balance between the good and the bad IL-1 proinflammatory effects in endometriosis. Curr Med Chem 2018;25:2105-2121. http://www.eurekaselect.com/158945/article
Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study.
Scala C, Leone Roberti Maggiore U, Barra F, Venturini PL, Ferrero S. Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study. Eur J Obstet Gynecol Reprod Biol 2018;222:89-94.https://www.ejog.org/article/S0301-2115(18)30032-0/fulltext